AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
LENALIDOMIDE in Tunisia
8 products registered with DPM — 0 active, 8 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SOTIRA Gélule / 5 mg | 6653764H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| SOTIRA Gélule / 25 mg | 66537623H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| SOTIRA Gélule / 10 mg | 6653761H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| SOTIRA Gélule / 15 mg | 6653362H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| LENALIDOMIDE NEAPOLIS Gélule / 5 mg | 9393211H | NEAPOLIS PHARMA | expired | 28 Oct 2021 |
| LENALIDOMIDE NEAPOLIS Gélule / 10 mg | 9393212H | NEAPOLIS PHARMA | expired | 28 Oct 2021 |
| LENALIDOMIDE NEAPOLIS Gélule / 15 mg | 9393213H | NEAPOLIS PHARMA | expired | 28 Oct 2021 |
| LENALIDOMIDE NEAPOLIS Gélule / 25 mg | 9393214H | NEAPOLIS PHARMA | expired | 28 Oct 2021 |
LENALIDOMIDE — DPM Registration Details
DPM (Tunisia) has 8 registered products containing LENALIDOMIDE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track LENALIDOMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.